Screening for Anti-diabetic Effects of Prescribed Korean Traditional Medicines
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Herb extracts commercially used in Korea were screened for PPAR-γ agonist test and α-glucosidase inhibition assay. Total 16 herb plants had a PPAR-γ agonist activity. Specially, Alisma orientale Juz (108.41%), Ephedra sinica (98.22%), Sasa japonica Makino var. purpurascens Nakai (140.68%), Astragalus membranaceus Bunge (106.79%) and Cnidium officinale Makino (113.00%) showed high PPAR-γ agonist activity rate compared with rosiglitazone’s (167.46%). And Cornus officinalis S. et Z. (90.3%), Cinnamomum cassia Blume (89.2%), Psoralea corylifolia L. (89.8%), Paeonia japonica (Makino) Miyabe (92.4%) and Paeonia suffruticosa Andr (93.2%), showed high α-glucosidase inhibition rates. These results support previous reports of the efficacy of Oriental medicinal plants used for diabetes mellitus.
Abstract
Herb extracts commercially used in Korea were screened for PPAR-γ agonist test and α-glucosidase inhibition assay. Total 16 herb plants had a PPAR-γ agonist activity. Specially, Alisma orientale Juz (108.41%), Ephedra sinica (98.22%), Sasa japonica Makino var. purpurascens Nakai (140.68%), Astragalus membranaceus Bunge (106.79%) and Cnidium officinale Makino (113.00%) showed high PPAR-γ agonist activity rate compared with rosiglitazone’s (167.46%). And Cornus officinalis S. et Z. (90.3%), Cinnamomum cassia Blume (89.2%), Psoralea corylifolia L. (89.8%), Paeonia japonica (Makino) Miyabe (92.4%) and Paeonia suffruticosa Andr (93.2%), showed high α-glucosidase inhibition rates. These results support previous reports of the efficacy of Oriental medicinal plants used for diabetes mellitus.
참고문헌 (23)
- Caspary, W. F., "Sucrose malabsorption in man after ingestion of alpha-glucosidehydrolase inhibitor", Lancet, 1, pp.1231~1233 (1978)
- Cerasi, E., "Type 2 diabetes: to stimulate or not to stimulate the cell", Metabolism, 49(suppl 2), pp.1~2 (2000)
- Charpentier, G., "Management of drugs affecting blood glucose in diabetic patients with renal failure", Diabet. Metabol, 26, pp.73~85 (2000)
- Cheng, A., "Oral antihyperglycemic therapy for type 2 diabetes mellitus", Can. Med. Assoc. J, 172, pp.213~226 (2005)
- Chiasson, J. L., "The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial", Ann. Int. Med, 15, pp.928~935 (1994)
- Evans, R. M., "PPARs and the complex journey to obesity", Nat. Med, 10, pp.355~361 (2004)
- Gerhold D. L., "Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferation-activated receptor-gamma agonists", Endocrinology, 143, pp.2106~2118 (2002)
- Hansen, B. C., "The metabolic X syndrome", Ann. NY Acad. Sci, 892, pp.1~24 (1999)
- Harnack, L. J., "Prevalence of use of herbal products by adults in the Minneapolis", St Paul, Minn, metropolitan area, 2001, pp.76, 688~694
- Huang, C., "Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway", Biochem. Biophys. Res. Commun, 348, pp.571~578 (2006)
- Kameda, K., "Insulin like action of trans-10-hydrixy-2-decanoicacid and its related substance", J. Trad. Med, 13, pp.456~457 (1996)
- Krenisky, J. M., "Isolation and antihyperglycemic activity of bakuchoil from Otholobium pubsecens (Fabaceae), a Peruvian medical plant used for the treatment of diabetes", Biol. Pharm. Bull, 22, pp.1137~1140 (1999)
- Lebovitz, H.E., "Postprandial hyperglycaemic state: importance and consequences", Diabetes. Res. Clin. Pract, 40, pp.S27~S28 (1998)
- Li, Y., "Punica granatum flower extract, a potent alpha-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats", J. Ethnopharmacol, 99, pp.239~244 (2005)
- Marles, R., "Antidiabetic plants and their active constituents", Phytomedicine, 2, pp.137~165 (1995)
- Matthaei, S., "Pathophysiology and pharmacological treatment of insulin resistance", Endocr. Rev, 21, pp.585~618 (2000)
- Moller, D.E., "New drug targets for type 2 diabetes and the metabolic syndrome", Nature, 414, pp.821~827 (2001)
- Pakala, R., "Peroxisome proliferator-activated receptor gamma, its role in metabolic syndrome", Cardiovasc. Radiat. Med, 5, pp.97~103 (2004)
- Stales, B., "Therapeutic roles of peroxisome proliferatoractivated receptor agonists", Diabetes, 54, pp.2460~2470 (2005)
- Skyler, J., "Diabetes mellitus: pathogenesis and treatment strategies", J. Med. Chem, 47, pp.4113~4117 (2004)
- van de Venter, M., "Antidiabetic screening and scoring of 11 plants traditionally used in South Africa", J. Ethnopharmacol, 119, pp.81~86 (2008)
- Wolsko, P.M., "Insurance coverage, medical conditions, and visits to alternative medicine providers: results of a national survey", Arch. Intern. Med, 162, pp.281~287 (2002)
- Yamamoto, H., "Reduced IRS-2 and GLUT4 expression in PPARgamma2-nduced adipocytes derived from C", EBP beta and C, J. Cell. Sci, pp.2002, 115[DOI]